Phaeochromocytoma in pregnancy: timing of surgery, mode of delivery and magnesium
- PMID: 27579085
- PMCID: PMC4989630
- DOI: 10.1258/om.2010.100033
Phaeochromocytoma in pregnancy: timing of surgery, mode of delivery and magnesium
Abstract
Phaeochromocytoma in pregnancy is rare. It is associated with high rates of fetal and maternal mortality especially in undiagnosed cases. There are no reliable data comparing outcomes regarding the timing of removal of tumour, or comparing outcomes between vaginal and caesarean delivery. Management should be individualized based upon consultation between the mother, obstetrician, anaesthetist, surgeon and physician. Magnesium infusion should be considered peripartum and/or at the timing of tumour resection.
Keywords: endocrinology; genetic testing; magnesium; phaeochromocytoma; pregnancy.
References
-
- Sarathi V, Lila AR, Bandgar TR, Menon PS, Shah NS. Pheochromocytoma and pregnancy: a rare but dangerous combination. Endocr Pract 2010;16:300–9 - PubMed
-
- Junglee N, Harries SE, Davies N, Scott-Coombes D, Scanlon MF, Rees DA. Pheochromocytoma in pregnancy: when is operative intervention indicated?. J Womens Health (Larchmt) 2007;16:1362–5 - PubMed
-
- Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv 1999;54:728–37 - PubMed
-
- James MF, Cronje L. Pheochromocytoma crisis: the use of magnesium sulfate. Anesth Analg 2004;99:680–6 - PubMed
Publication types
LinkOut - more resources
Full Text Sources